{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:42:15Z","timestamp":1760182935063,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.rdc.2012.08.015","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T21:24:54Z","timestamp":1346448294000},"page":"xvii-xxi","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preface"],"prefix":"10.1016","volume":"38","author":[{"given":"J\u00fcrgen","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9570","key":"10.1016\/j.rdc.2012.08.015_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2012.08.015_bib2","article-title":"The development of Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (Part II): Validation and final selection","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/acr.21688","article-title":"Patients with non-radiographic axial spondyloarthritis differ from patients with ankylosing spondylitis in several aspects","author":"Kiltz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2012.08.015_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2009.110767","article-title":"Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis\u2014a consensual approach by the ASAS\/OMERACT MRI Group","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2011.150680","article-title":"Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI study group","author":"Hermann","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2012.08.015_bib7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.130559","article-title":"Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis","volume":"69","author":"Braun","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2012.08.015_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/ard.2011.151167","article-title":"Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2012.08.015_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute phase reactants and cigarette smoking status predict radiographic progression in the spine in early axial spondyloarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2012.08.015_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/annrheumdis-2011-200208","article-title":"MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis","volume":"71","author":"van der Heijde","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2012.08.015_bib11","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/art.30393","article-title":"Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis","volume":"63","author":"Chiowchanwisawakit","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.015_bib12","article-title":"Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification","author":"Maksymowych","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2011-200508","article-title":"The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study","author":"Kiltz","year":"2012","journal-title":"Ann Rheum Dis"},{"year":"2012","series-title":"Sensitivity and discriminatory ability of the ankylosing spondylitis disease activity score in patients treated with etanercept or sulphasalazine in the ASCEND trial","author":"van der Heijde","key":"10.1016\/j.rdc.2012.08.015_bib14"},{"key":"10.1016\/j.rdc.2012.08.015_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2010.147744","article-title":"Predicting the outcome of ankylosing spondylitis therapy","author":"Vastesaeger","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab\u2014a double-blind placebo controlled multicenter trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"year":"2011","series-title":"Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years\u2014early clinical response predicts long-term outcome","author":"Baraliakos","key":"10.1016\/j.rdc.2012.08.015_bib17"},{"issue":"4","key":"10.1016\/j.rdc.2012.08.015_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","article-title":"Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis","volume":"60","author":"Barkham","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2012.08.015_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","article-title":"Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib20","article-title":"Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial","author":"Song","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-eular.2240","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised, placebo-controlled trial (ABILITY-1)","author":"Sieper","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2012.08.015_bib22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/annrheumdis-2011-200308","article-title":"Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study","volume":"71","author":"Braun","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2012.08.015_bib23","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/kem166","article-title":"Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-\u03b1 antibody infliximab","volume":"46","author":"Baraliakos","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.rdc.2012.08.015_bib24","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/rheumatology\/ken357","article-title":"What is the most important outcome in ankylosing spondylitis?","volume":"47","author":"Braun","year":"2008","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.rdc.2012.08.015_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"van der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2012.08.015_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/BOR.0b013e3283524b82","article-title":"Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?","volume":"24","author":"Kiltz","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2012.08.015_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2011-201252","article-title":"Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort","author":"Poddubnyy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.015_bib29","article-title":"Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","author":"Kroon","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2012.08.015_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/acr.20671","article-title":"NSAID-intake according to the ASAS score in clinical trials evaluating TNF blockers: The example of etanercept in advanced ankylosing spondylitis","volume":"64","author":"Dougados","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X12000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X12000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:10:53Z","timestamp":1760181053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X12000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0889857X12000749"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2012.08.015","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preface","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2012.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}